PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institut für Klinische Pharmakologie und Toxikologie, Germany.\', \'Université Paris-Descartes; AP-HP, Hôpital Européen Georges-Pompidou, Hypertension Department and DMU CARTE; INSERM, CIC1418, Paris, France.\', \'Department of Hypertension, National Institute of Cardiology, Warsaw, Poland.\', \'Institute of Cardiovascular & Medical Sciences BHF Glasgow Cardiovascular Research Centre; Glasgow, UK and Jagiellonian University, Collegium Medicum, Krakow, Poland.\', \'Division of Cardiology, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium.\', \'The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.\', \'Service of Nephrology and Hypertension, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/cvr/cvaa097
?:hasPublicationType
?:journal
  • Cardiovascular research
is ?:pmid of
?:pmid
?:pmid
  • 32293003
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.002
?:rankingScore_hIndex
  • 195
is ?:relation_isRelatedTo_publication of
?:title
  • Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all